These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2339369)

  • 1. Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase.
    Vila V; Regañón E; Aznar J; Lacueva V; Ruano M; Laiz B
    Thromb Res; 1990 Mar; 57(5):783-94. PubMed ID: 2339369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
    Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD
    Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.
    Regañón E; Vila V; Aznar J; Laiz B
    Clin Chim Acta; 1989 Sep; 184(1):7-17. PubMed ID: 2532081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
    Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
    Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of thrombin-antithrombin complexes during thrombolytic therapy in patients with myocardial infarction.
    Tripodi A; Bottasso B; Mannucci PM
    Ric Clin Lab; 1990; 20(3):197-202. PubMed ID: 2122514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of streptodecase and heparin on the state of hemostasis in patients with acute myocardial infarction].
    Mazaev AV; Suvorova LA; Barbakar' NG
    Kardiologiia; 1984 Jul; 24(7):62-6. PubMed ID: 6482158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction.
    Col JJ; Col-De Beys CM; Renkin JP; Lavenne-Pardonge EM; Bachy JL; Moriau MH
    Am J Cardiol; 1989 May; 63(17):1185-92. PubMed ID: 2653017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction.
    Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W
    J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
    Hillis LD; Borer J; Braunwald E; Chesebro JH; Cohen LS; Dalen J; Dodge HT; Francis CK; Knatterud G; Ludbrook P
    J Am Coll Cardiol; 1985 Nov; 6(5):957-62. PubMed ID: 4045046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of fibrinogen by the DuPont aca and Dade methods in patients receiving streptokinase infusions.
    Lurie AA; Gross LF; Rogers WJ
    Am J Clin Pathol; 1985 Oct; 84(4):526-9. PubMed ID: 4036883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
    Violaris AG; Trudgill NJ; Rowlands L; Gunn J; Tsikaderis D; Campbell S
    Coron Artery Dis; 1994 Mar; 5(3):257-65. PubMed ID: 8199741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
    Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Arnout J; Simoons M; de Bono D; Rapold HJ; Collen D; Verstraete M
    J Am Coll Cardiol; 1992 Sep; 20(3):513-9. PubMed ID: 1512327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
    Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G
    Angiology; 2006; 57(3):283-93. PubMed ID: 16703188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.